Advanced oncology pipeline including more than 20 active Phase 2 and Phase 3 clinical trials with a strategic focus on two priority pan-tumor programs: next-generation immunomodulator candidate BNT327 ...

The full audited consolidated financial statements as of and for the year ended December 31, 2024, can be found in BioNTech's Annual Report on Form 20-F filed today with the United States Securities ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid ...

Despite scientific advancements made during the COVID pandemic, growing vaccine hesitancy and the politicization of public health leave the U.S. vulnerable to future pandemics, according to experts ...

Republicans have proposed legislation in several states to ban the pioneering technology used in covid shots. Many doctors ...

A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the disease from coming back. The trial was tiny, just 16 patients, but it’s ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Sky-high egg prices have drawn renewed attention to the bird flu outbreak, which has caused more than 166 million wild and ...

High-profile Republican priorities are advancing after the Iowa Legislature's first "funnel" deadline on Friday, while others ...

The trial was tiny, just 16 patients, but it’s eliciting a sentiment not normally associated with this brutal disease of ...

Mutual of America Capital Management LLC trimmed its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 2.6% during the ...

Cornell researchers have developed a stable, multi-target vaccine offering long-lasting protection against COVID-19 and influenza, with promising results in mice. Cornell University researchers have ...